Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Stopping a Single Enzyme Could Help Treat Leukemia
EPFL scientists show how inactivating a single enzyme could effectively eradicate an aggressive form of leukemia. The principles could apply to other cancers as well.
Cell that Replenishes Heart Muscle Found by UT Southwestern Researchers
Researchers devise a new cell-tracing technique to detect cells that do replenish themselves.
Researchers Find Molecular Mechanisms within Fetal Lungs that Initiate Labor
Biochemists found that steroid receptor coactivators 1 and 2 (SRC-1 and SRC-2) proteins control genes.
Protein Plays Unexpected Role in Embryonic Stem Cells
A protein long believed to only guard the nucleus also regulates gene expression and stem cell development.
Unpacking the Mysteries of Bacterial Cell Cycle Regulation
Molecular biologists report a surprising new role for one factor, CpdR, an adaptor that helps to regulate selective protein destruction, the main control mechanism of cell cycle progression in bacteria, at specific times.
EMBL Scientists Solve Decades-Old Cell Biology Puzzle
Behaviour of clathrin proteins, crucial for endocytosis, is clarified using new imaging techniques.
All Change for Bacterial Outer Membrane Proteins
The discovery of how a group of bacteria can rapidly adapt to changing growth conditions could have implications for future antibiotic development.
New Immunoregulation and Biomarker
Clinicians at LMU have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases.
Scientists Map Surface of Immune Cells
The immune system must constantly adapt to its environment in order to protect a body effectively. The so-called T cells are an important example in this regard. One of their functions is to form the immune system's "memory".
New Type of Drug Can Target All Disease-causing Proteins
Current drugs block the actions of only about a quarter of known disease-causing proteins, but Yale University researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.
Scroll Up
Scroll Down

Quantitative Proteomics For Biomarker Discovery and Validation: Prostate Cancer Case Study
Stephen Pennington, UCD Dublin, Professor of Proteomics, speaking at European Biomarkers Summit 2011.

Genome-scale Quantitative Tumour Proteomics for Cancer Biomarkers Discovery
Metodi Metodiev, Lecturer/Director of Proteomics Unit, University of Essex, speaking at European Biomarkers Summit 2011.

Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies
Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.

Development of a Blood Based Molecular Test to Aid in the Diagnosis of Schizophrenia
Emanuel Schwarz, Post Doctoral Researcher, University of Cambridge, speaking at European Biomarkers Summit 2011.

Pharmacogenomics of Drug Disposition: From Polymorphisms to Biomarkers
Urs A. Meyer, Emeritus Professor, Biozentrum, University of Basel speaking at ADMET Europe 2011

Quantitative Proteomics For Biomarker Discovery and Validation: Prostate Cancer Case Study
Stephen Pennington, Professor of Proteomics, UCD Dublin, speaking at European Biomarkers Summit 2010.

Adding Value to Biomarker Development from the Regulatory Perspective
Patricia Hurley, Head of Biomarkers, ERA Consulting, speaking at European Biomarkers Summit 2010.

Approaches for the Identification of New Biomarkers for Alzheimer's Disease
Christian Czech, CNS Researcher, F. Hoffman-La Roche, speaking at European Biomarkers Summit 2010.

Urine Molecular Profiling Distinguishes Health and Disease: A Fresh View on Diagnostics
Simone Koenig, Professor, University of Munster, speaking at European Biomarkers Summit 2010.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 150
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters